Breaking News

Frontage Bolsters Clinical Services Capabilities

Unveils plans to provide full service human radiolabeled absorption, metabolism, and excretion study capabilities.

By: Contract Pharma

Contract Pharma Staff

Frontage Laboratories and Frontage Clinical Services have unveiled plans to provide full service human radiolabeled Absorption, Metabolism, and Excretion (hAME) study capabilities, subject to receipt of required regulatory approvals.   Building on over 20 years of experience in early phase clinical research study conduct, data management and biometric services, Frontage Clinical Services is expanding study conduct capabilities to include human AME studies. This service complements the existing k...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters